Data are point estimate of HR (illustrated by the diamond symbol) and range of 2-sided 95% CI of the HR
24, the OFA described the decision as reckless and arbitrary and said it will deprive patients of a vital treatment for type 2 diabetes, obesity, cardiovascular disease and other serious medical conditions. The group also alleged that significant issues remain with the supply of these drugs, saying FDA officials acted to benefit special interests. If ever an agency action were arbitrary, capricious, and contrary to law, this is it, the OFA added in its lawsuit
Medical providers evaluate health history and treatment goals before recommending a suitable option
Additionally, the decline in estimated glomerular filtration rate (eGFR) was significantly slowed by 0.87 mL/min/1.73 m 2 per year with semaglutide and 0.26 mL/min/1.73 m 2 per year with liraglutide
All ELISA kits were used according to the manufacturer's instructions
February 3, 2026- Streamlined protocal for filing vison loss lawsuits in Federal MDL The U.S